SEC Form D private-offering filing

Contraline, Inc.

A new SEC Form D private-offering notice from Charlottesville, VA, a $115,929,658 filer-stated offering target in Biotech. The source filing is one click away.

Contraline, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing Adam, an implantable polymer gel male contraceptive, aiming for late-stage development

Filed 2026-06-10Filed to raise $115,929,658First money in 2026-05-29Raised so far $55,804,741HQ (as filed) Charlottesville, VASector Biotech Stage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified contraline.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.